BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BOLD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	20:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLD	Boundless Bio Inc
2024/05/13	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLD	Boundless Bio Inc
2024/05/13	20:00	Business Wire	Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:BOLD	Boundless Bio Inc
2024/05/06	21:00	Business Wire	Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024	NASDAQ:BOLD	Boundless Bio Inc
2024/04/11	21:00	Business Wire	Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications	NASDAQ:BOLD	Boundless Bio Inc
2024/04/08	21:00	Business Wire	Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:BOLD	Boundless Bio Inc
2020/02/15	07:23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/15	06:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/15	06:15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/12	06:41	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
2020/02/06	01:27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2020/01/27	23:38	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:BOLD	Boundless Bio Inc
2020/01/21	20:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
2020/01/21	20:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
2019/12/04	09:13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.	NASDAQ:BOLD	Boundless Bio Inc
2019/12/03	08:01	Business Wire	Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics	NASDAQ:BOLD	Boundless Bio Inc
2019/11/27	06:01	Business Wire	Audentes Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
2019/11/13	07:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2019/11/13	02:13	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2019/11/08	07:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BOLD	Boundless Bio Inc
2019/11/08	06:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2019/11/08	06:01	Business Wire	Audentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
2019/10/31	20:00	Business Wire	Audentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...	NASDAQ:BOLD	Boundless Bio Inc
2019/10/09	19:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2019/10/05	20:01	Business Wire	Audentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...	NASDAQ:BOLD	Boundless Bio Inc
2019/10/05	07:00	Business Wire	Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BOLD	Boundless Bio Inc
2019/10/01	21:00	Business Wire	Audentes Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
2019/09/30	21:00	Business Wire	Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...	NASDAQ:BOLD	Boundless Bio Inc
2019/09/26	07:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2019/09/17	05:18	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc